Heavy menstrual bleeding: assessment and management
National Institute for Health and Care Excellence
Between 20 and 30% of women in England and Wales of reproductive age were affected by heavy menstrual bleeding (HMB) in 2011. Although HMB is not associated with significant mortality and considered unimportant by some healthcare professionals, the condition can interfere with women’s physical, emotional, social, and material quality of life. It is estimated to be the fourth most common reason for referral to gynaecological services.
This updated Guidelines summary covers diagnosis of HMB, information for patients, and possible pharmaceutical interventions.